Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2024-06, Vol.38 (6), p.1419-1422
Hauptverfasser:	Lu, Wenyi, Lyu, Hairong, Xiao, Xia, Bai, Xue, Zhang, Meng, Wang, Jiaxi, Pu, Yedi, Meng, Juanxia, Zhang, Xiaomei, Zhu, Haibo, Yuan, Ting, Wang, Bing, Jin, Xin, Cao, Xinping, Wang, Zhao, Xie, Tianle, Meng, Haotian, Stepanov, Alexey V., Gabibov, Alexander G., An, Yuxin, Sun, Rui, Zhang, Yu, Maschan, Mikhail A., Zhu, Zunmin, Zhang, Hongkai, Zhao, Mingfeng
Format:	Artikel
Sprache:	eng
Schlagworte:	13/21 42/109 631/250/1904 631/250/251 692/699/1541/1990/283/2125 82/80 96/31 Anemia Bone marrow Cancer Research CD19 antigen Critical Care Medicine Hematology Hematopoietic stem cells Intensive Internal Medicine Letter Leukemia Leukocytes Leukopenia Lymphocytes Lymphocytes T Medicine Medicine & Public Health Oncology Patients Remission (Medicine) Stem cell transplantation Stem cells Thrombocytopenia Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!